CAC
Cowen and Company Portfolio holdings
AUM
$2.9B
This Quarter Return
+5.03%
1 Year Return
+104.28%
3 Year Return
+119.87%
5 Year Return
+632.2%
10 Year Return
–
AUM
$1.05B
AUM Growth
+$1.05B
(+3.1%)
Cap. Flow
+$37.3M
Cap. Flow
% of AUM
3.56%
Top 10 Holdings %
Top 10 Hldgs %
50%
Holding
798
New
223
Increased
216
Reduced
73
Closed
121
Top Buys
| 1 |
Immunocore
IMCR
|
$47.5M |
| 2 |
ARK Innovation ETF
ARKK
|
$35.2M |
| 3 |
Avidity Biosciences
RNA
|
$24.9M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$20.8M |
| 5 |
Playtika
PLTK
|
$9.16M |
Top Sells
Sector Composition
| 1 | Healthcare | 34.11% |
| 2 | Financials | 8.03% |
| 3 | Materials | 6.97% |
| 4 | Technology | 3.58% |
| 5 | Industrials | 3.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ARK Innovation ETF
ARKK
$7.45B
| $131M | 12.57% | 3,483,400 +933,400 | +37% | +$35.2M |
|
2
Sylvamo
SLVM
$1.86B
| $72.9M | 6.97% | 2,150,000 | – | – |
|
|
3
Avidity Biosciences
RNA
$5.99B
| $61.9M | 5.92% | 3,788,366 +1,524,216 | +67% | +$24.9M |
|
|
4
Immunocore
IMCR
$1.62B
| $47.5M | 4.54% | +1,011,670 | New | +$47.5M |
|
5
Establishment Labs
ESTA
$1.2B
| $45.7M | 4.37% | 836,654 | – | – |
|
6
Adicet Bio
ACET
$59.9M
| $34.7M | 3.32% | 2,443,246 -534 | -0% | -$7.59K |
|
7
FTAI Aviation
FTAI
$15.8B
| $28.1M | 2.69% | 1,874,508 +163,958 | +10% | +$2.46M |
|
|
CUTR
8
DELISTED
Cutera, Inc.
CUTR
| $27.2M | 2.6% | 596,213 -92 | -0% | -$4.2K |
|
9
Innoviz Technologies
INVZ
$335M
| $26.4M | 2.53% | 5,066,390 +295,000 | +6% | +$1.54M |
|
|
10
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $20.8M | 1.99% | +726,608 | New | +$20.8M |
|
11
Energy Transfer Partners
ET
$60.8B
| $20.7M | 1.98% | 1,875,000 +440,000 | +31% | +$4.85M |
|
12
Sumitomo Mitsui Financial
SMFG
$105B
| $20.2M | 1.93% | 3,677,105 -1,999,500 | -35% | -$11M |
|
13
Fulcrum Therapeutics
FULC
$351M
| $19M | 1.82% | 2,347,989 -37,896 | -2% | -$307K |
|
|
AVDL
14
Avadel Pharmaceuticals
AVDL
$1.43B
| $18.7M | 1.79% | 3,732,778 | – | – |
|
|
SCPL
15
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $17.3M | 1.66% | 1,471,246 +125,000 | +9% | +$1.47M |
|
16
Rocket Pharmaceuticals
RCKT
$354M
| $16M | 1.53% | 999,588 -412 | -0% | -$6.58K |
|
|
PEGR
17
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $14.8M | 1.41% | 1,500,000 | – | – |
|
|
HCVIU
18
DELISTED
Hennessy Capital Investment Corp. VI Unit
HCVIU
| $14.6M | 1.39% | 1,500,000 | – | – |
|
19
Apyx Medical
APYX
$75.3M
| $12.8M | 1.23% | 2,854,841 +36,500 | +1% | +$164K |
|
20
Cantaloupe
CTLP
$797M
| $11.5M | 1.1% | 3,855,240 +892,052 | +30% | +$2.66M |
|
21
Stoke Therapeutics
STOK
$1.08B
| $9.88M | 0.94% | 769,169 -740,451 | -49% | -$9.51M |
|
|
22
Playtika
PLTK
$1.39B
| $9.16M | 0.88% | +975,000 | New | +$9.16M |
|
23
Tarsus Pharmaceuticals
TARS
$2.47B
| $8.94M | 0.86% | 522,329 -12,195 | -2% | -$209K |
|
|
JNCE
24
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $8.54M | 0.82% | 3,647,430 +804,281 | +28% | +$1.88M |
|
25
Relmada Therapeutics
RLMD
$37.2M
| $8.01M | 0.77% | 216,441 -850,413 | -80% | -$31.5M |
|